Today’s Solutions: April 21, 2024

It took about 50 years to develop an AI system capable of playing chess to the level of a grandmaster. Now, programmers have developed a new AI player, not one with the goal of winning chess games, but rather learning how to lose them. 

Researchers from Cornell University developed the AI chess player, known as Maia, to learn more about how humans make mistakes and predict human error. The hope is that once perfected via chess, Maia will be able to predict human fallibility and become better at assisting and negotiating with humans. 

One potential application for the technology is in the medical field. A medical training system that anticipates human error can train doctors and medical staff to also anticipate those common mistakes. 

Maia was developed using an open-source clone of Alpha Zero, a revolutionary AI program created by the Alphabet subsidiary DeepMind. The program was modified to reinforce when it accurately predicted human behavior. This modification of AI to replicate human behavior, rather than perform at the highest possible standard, opens up a whole host of new avenues for AI applications.

In addition to medical training, the program could be used in chess itself to help players prepare for matches by going up against an AI system that perfectly replicates their future opponent’s playing style. It could also be used in negotiation practice or interview preparation.

Solutions News Source Print this article
More of Today's Solutions

3 simple ways to save an extra $250 per month

Everyone loves to save money, so here are three easy ways you can free up $250 in your budget per month. Cancel subscriptions you ...

Read More

APA, AAPI, APIDA or AANHPI? The history and significance of the “Asian Americ...

“The journey of a thousand miles begins with one step.” ― Lao Tzu By Arielle Tiangco Weeks ago, seated cross-legged on my couch, I ...

Read More

Playing video games benefit key regions of the brain

A recent study from Georgia State University found that sensorimotor decision-making skills were superior in regular video game players to those that didn’t play ...

Read More

Novel blood cancer treatment effective in three-fourths of trial patients

According to new findings from an ongoing Phase 1/2 clinical research trial, a novel investigational immunotherapy resulted in successful response rates for 73 percent ...

Read More